Status:
UNKNOWN
Study of CT and MR in the Gastric Cancer
Lead Sponsor:
Henan Cancer Hospital
Conditions:
Gastric Cancer Stage
CT
Eligibility:
All Genders
18-80 years
Brief Summary
It is very significant that assessing staging in gastric cancer patients before surgery, furthermore, determining the optimize surgical strategy ,predict the the efficacy of neoadjuvant therapy for pa...
Detailed Description
To explore the value of CT and MR using multiple sequences, including T2-TSE-BLADE, T2 maps StarVIBE, and iShim-DWI in evaluating the preoperative TN staging and prediction of response to neoadjuvant ...
Eligibility Criteria
Inclusion
- Consecutive patients with preoperative pathologically con-firmed gastric cancer by endoscopy and preoperative imaging data (esophagography\\CT\\EUS\\MRI) were included.
- No contraindications for MRI examination. No contraindications contrast.
- The patients participate in this study with informed consent.
Exclusion
- The patients couldn't performed MSCT or MR scanning or artefacts affect the evaluation.
- The patients are extremely anxious and uncooperative about surgery or neoadjuvant therapy .
- PatientsThe patients refuse to participate in the project.
- Other situations considered by investigators not meet the inclusion criteria.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04028375
Start Date
September 1 2019
End Date
December 1 2023
Last Update
April 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henan Cancer Hospital
Zhengzhou, China